SEC Filing Details
Document Details
Form
Filing Date
Sep 23, 2024
Document Date
Sep 12, 2024
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Fulcrum Therapeutics
Issuer
Fulcrum Therapeutics, Inc.
Filer
RA CAPITAL MANAGEMENT, L.P.